Target intelligence / Profile preview

RNA, U6 small nuclear 1190, pseudogene (RNU6-1190P)

Target
RNU6-1190P
Molecular classification
Other (Non-coding RNA pseudogene)
01

Overview

RNU6-1190P is a pseudogene derived from the U6 small nuclear RNA (snRNA) gene, which is a component of the spliceosome complex involved in pre-mRNA splicing in eukaryotes[3][1]. However, as a pseudogene, RNU6-1190P does not encode a functional RNA and does not contribute to spliceosomal activity or any other cellular process. The presence of U6 snRNA pseudogenes is attributed mainly to retrotransposition events, particularly LINE-1 (L1) mediated template switching, rather than conserved biological function[5][7]. While numerous pseudogenes in the genome mark the history of retrotransposon activity, neither this pseudogene nor related U6-derived pseudogenes are considered therapeutic targets, biomarkers, or candidates for pharmacological modulation. Their only utility is as markers for studying retrotransposition dynamics within the genome[5][7].\n\nFunctional U6 snRNA is highly conserved and essential for pre-mRNA splicing[3][1]. U6-derived pseudogenes like RNU6-1190P are non-functional sequences resulting from retrotranspositional copying events[5]. They can be used in research as indicators of retrotransposition activity but have no disease, drug target, or biomarker relevance[5][7].\n\nRNU6-1190P is a non-functional pseudogene, not a therapeutic or physiological molecular target; it serves only as a genomic marker of retrotransposition and lacks any biological, clinical, or pharmacological significance[2][5][7].

Other names
RNU6-1190P

Beyond the preview

Go deeper on RNA, U6 small nuclear 1190, pseudogene (RNU6-1190P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1190, pseudogene (RNU6-1190P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call